Webinar on the European Requirements for the CE-Certification of Medical Devices and In Vitro Diagnostics
Our partner, Evnia, held a webinar on the European Requirements for the CE-Certification of Medical Devices and In...
Read more
Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease.
Learn moreIn a Nutshell
2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.
Latest News
2D-BioPAD at the 14th Panhellenic Conference on Alzheimer’s Disease & 6th Mediterranean Conference on Neurodegenerative Diseases
2D-BioPAD will participate in the 14th Panhellenic Conference on Alzheimer’s Disease & 6th Mediterranean Conference on Neurodegenerative Diseases,...
Read more
Smart ideas to prevent dementia
On January 19th, 2025, the Municipal Regional Theatre of Serres hosted an informative event on “Dementia: Prevention and...
Read more
Introduction to the European Requirements for the CE-Certification of Medical Devices and In Vitro Diagnostics
As a member of the 2D-BioPAD Consortium, Evnia hosts a webinar to discuss the basics of European Regulations...
Read more
Consortium Partners
